DSAEK yields better 5-year graft survival than PK in Asian eyes
Click Here to Manage Email Alerts
Descemet’s stripping automated endothelial keratoplasty resulted in better graft survival than PK in Asian patients with endothelial dystrophy, according to a study.
Data were culled from the Singapore Corneal Transplant Registry. The review included 828 consecutive patients who underwent DSAEK (423 eyes) or PK (405 eyes) for bullous keratopathy or Fuchs’ endothelial dystrophy at the Singapore National Eye Center.
Surgeries were performed using standardized techniques for both PK and DSAEK.
A large majority of patients were Chinese (76.6%) and more patients had bullous keratopathy than Fuchs’ endothelial dystrophy (68.1% and 31.9%, respectively; P < .001).
Of patients who underwent routine endothelial cell density (ECD) evaluation, ECD cell loss was found to be significantly greater in the PK group than in the DSAEK group. Furthermore, cumulative graft rejection was greater in the PK group than in the DSAEK group (14.1 vs. 5%; P < .001). Cumulative graft survival was significantly decreased in eyes with bullous keratopathy compared with eyes with Fuchs’ endothelial dystrophy (53.7 % vs. 81.9%; P < .001), and the greatest incidence of graft failure was caused by cytomegalovirus in PK eyes compared with DSAEK eyes. – by Kate Sherrer
Disclosure: Mehta and Tan have patents with Endoglide and receive royalties from Network Medical. All other authors report no relevant financial disclosures.